Biosyent Stock Filter Stocks by Fundamentals
RX Stock | CAD 11.70 0.07 0.60% |
Biosyent fundamentals help investors to digest information that contributes to Biosyent's financial success or failures. It also enables traders to predict the movement of Biosyent Stock. The fundamental analysis module provides a way to measure Biosyent's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biosyent stock.
Biosyent | Shares Owned by Insiders |
Biosyent Current Valuation Drivers
We derive many important indicators used in calculating different scores of Biosyent from analyzing Biosyent's financial statements. These drivers represent accounts that assess Biosyent's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Biosyent's important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Market Cap | 85.1M | 102.8M | 104.8M | 107.0M | 96.3M | 101.1M | |
Enterprise Value | 73.5M | 84.2M | 88.3M | 100.2M | 90.2M | 94.7M |
Biosyent Fundamentals
Return On Equity | 0.21 | ||||
Return On Asset | 0.13 | ||||
Profit Margin | 0.21 % | ||||
Operating Margin | 0.22 % | ||||
Current Valuation | 119.09 M | ||||
Shares Outstanding | 11.59 M | ||||
Shares Owned By Insiders | 33.63 % | ||||
Shares Owned By Institutions | 1.41 % | ||||
Number Of Shares Shorted | 357 | ||||
Price To Earning | 16.61 X | ||||
Price To Book | 3.61 X | ||||
Price To Sales | 3.99 X | ||||
Revenue | 31.59 M | ||||
Gross Profit | 22.86 M | ||||
EBITDA | 7.99 M | ||||
Net Income | 6.46 M | ||||
Cash And Equivalents | 22.46 M | ||||
Cash Per Share | 1.59 X | ||||
Total Debt | 1.22 M | ||||
Current Ratio | 10.10 X | ||||
Book Value Per Share | 2.96 X | ||||
Cash Flow From Operations | 5.83 M | ||||
Short Ratio | 0.01 X | ||||
Earnings Per Share | 0.60 X | ||||
Target Price | 11.75 | ||||
Beta | 0.93 | ||||
Market Capitalization | 135.07 M | ||||
Total Asset | 41.53 M | ||||
Retained Earnings | 27.53 M | ||||
Working Capital | 30.34 M | ||||
Annual Yield | 0.02 % | ||||
Net Asset | 41.53 M |
About Biosyent Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biosyent's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biosyent using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biosyent based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Biosyent Stock Analysis
When running Biosyent's price analysis, check to measure Biosyent's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biosyent is operating at the current time. Most of Biosyent's value examination focuses on studying past and present price action to predict the probability of Biosyent's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biosyent's price. Additionally, you may evaluate how the addition of Biosyent to your portfolios can decrease your overall portfolio volatility.